Max Healthcare’s Oncology Revenue Share Declines to 21% Amid CGHS Drug Supply Changes
Max Healthcare’s oncology segment contributed 21% to its inpatient revenue in Q2 FY27, compared with 26% in the corresponding quarter…
CGHS Drug
Read More
November 4, 2026
- Max Healthcare’s Oncology Revenue Share Declines to 21% Amid CGHS Drug Supply Changes
- Centre Proposes More Entry Points for Drug and Medical Device Imports
- TNAI-Uttarakhand President Dr. Rajesh Kumar Sharma Visits TISHHA, Discusses Nursing Education and Professional Development
- Chip Crisis Puts Medical Equipment Manufacturing and Hospital Procurement Under Pressure